Genmab A/S
GMAB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001434265
No open-market purchases or sales by Genmab A/S insiders were filed in the last 90 days; 291 institutions reported holding it in 13F filings for Q2 2026, worth $2.81B in total; no superinvestor holds it.
Other share classesGNMSF
Superinvestors holding GMAB, Q2 2026
No superinvestor reported holding GMAB in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of GMAB each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q2 2021
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)